NHS England issued an interim clinical commissioning policy statement on sofosbuvir in April 2014, outlining the criteria for funding for the treatment of hepatitis C in adults in England. The NHS England policy position will be reviewed following publication of the final NICE guidance.
According to a PharmaTimes report, patients will not gain access to sofosbuvir until later this year, as NHS England has requested extra time to allow it to ensure that necessary funding arrangements are in place.